Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases

about

Depletion of Alveolar Macrophages Does Not Prevent Hantavirus Disease Pathogenesis in Golden Syrian Hamsters Imaging of pulmonary disease in scleroderma with J001X scintigraphy.Interstitial lung disease of systemic sclerosis.

P2860

Q26314485-BFE1AC68-0ED6-4F81-B88D-12BA54A253D1 Q36566458-4FA55AC4-6C05-4C0E-893D-4A11A9458045 Q40468554-BA9B8127-31C7-46E4-B30C-F7C50E570D26

P2860

Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases

Item

http://www.wikidata.org/entity/Q36176957

description

1988 nî lūn-bûn

@nan

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

1988年论文

@zh

1988年论文

@zh-cn

name

Activated alveolar macrophages ...... in collagen vascular diseases

@ast

Activated alveolar macrophages ...... in collagen vascular diseases

@en

type

Item

label

Activated alveolar macrophages ...... in collagen vascular diseases

@ast

Activated alveolar macrophages ...... in collagen vascular diseases

@en

prefLabel

Activated alveolar macrophages ...... in collagen vascular diseases

@ast

Activated alveolar macrophages ...... in collagen vascular diseases

@en

P1476

Activated alveolar macrophages ...... in collagen vascular diseases

@en

P2093

Aerts C

http://www.w3.org/2001/XMLSchema#string

Bart F

http://www.w3.org/2001/XMLSchema#string

Hatron PY

http://www.w3.org/2001/XMLSchema#string

Ouaissi A

http://www.w3.org/2001/XMLSchema#string

Tonnel AB

http://www.w3.org/2001/XMLSchema#string

Voisin C

http://www.w3.org/2001/XMLSchema#string

Wallaert B

http://www.w3.org/2001/XMLSchema#string

P2860

Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)

Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients.

Alveolitis: the key to the interstitial lung disorders.

Serum factor requirement for reactive oxygen intermediate release by rabbit alveolar macrophages

Lymphokines enhance the capacity of human monocytes to secret reactive oxygen intermediates.

Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders.

In vivo damage of rat lungs by oxygen metabolites.

Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis.

Pulmonary involvement in the collagen vascular diseases.

Interstitial pulmonary fibrosis--which cell is the culprit?

P304

24-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.43.1.24

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1988-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20323207

http://www.w3.org/2001/XMLSchema#string

P698

2832961

http://www.w3.org/2001/XMLSchema#string

P932

461084

http://www.w3.org/2001/XMLSchema#string

Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases

about

P2860

P2860

Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932